智通财经APP讯，三友医疗(688085.SH)发布公告，公司控股子公司苏州云合景从新材料科技有限公司(以下简称“云合景从”)之“表面多孔聚醚醚酮椎间融合器”于近日通过国家药品监督管理局医疗器械技术审评中心创新医疗器械特别审查程序(受理号：CQTS2500086)。
此次该产品进入创新医疗器械特别审查程序，在注册申报时将获得优先办理的权益，可有效缩短产品注册周期，加快产品的上市速度。该产品如获批上市，将进一步丰富公司的产品管线，对公司的业务产生积极影响。
智通财经APP讯，三友医疗(688085.SH)发布公告，公司控股子公司苏州云合景从新材料科技有限公司(以下简称“云合景从”)之“表面多孔聚醚醚酮椎间融合器”于近日通过国家药品监督管理局医疗器械技术审评中心创新医疗器械特别审查程序(受理号：CQTS2500086)。
此次该产品进入创新医疗器械特别审查程序，在注册申报时将获得优先办理的权益，可有效缩短产品注册周期，加快产品的上市速度。该产品如获批上市，将进一步丰富公司的产品管线，对公司的业务产生积极影响。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.